Page last updated: 2024-09-04

cryptotanshinone and Atrophy, Muscle

cryptotanshinone has been researched along with Atrophy, Muscle in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, Y; Chen, L; Guo, C; Wan, L; Xin, B; Yang, Q; Zhang, H; Zhang, J	1

Other Studies

1 other study(ies) available for cryptotanshinone and Atrophy, Muscle

Article	Year
Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway. Journal of ethnopharmacology, 2020, Oct-05, Volume: 260 Topics: Adenocarcinoma; Animals; Cachexia; Colonic Neoplasms; HEK293 Cells; HeLa Cells; Humans; Male; Mice, Inbred BALB C; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; Phenanthrenes; Phosphorylation; Signal Transduction; SKP Cullin F-Box Protein Ligases; STAT3 Transcription Factor; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Weight Loss	2020

Article

Year

Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.

Journal of ethnopharmacology, 2020, Oct-05, Volume: 260

Topics: Adenocarcinoma; Animals; Cachexia; Colonic Neoplasms; HEK293 Cells; HeLa Cells; Humans; Male; Mice, Inbred BALB C; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; Phenanthrenes; Phosphorylation; Signal Transduction; SKP Cullin F-Box Protein Ligases; STAT3 Transcription Factor; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Weight Loss

2020